Table 3.

Prevalence and persistence of type-specific low-risk human papillomavirus (HPV) in the total study population and by HIV status, n (%).

HPV type	Prevalent HPV				Persistent HPV
	Total	HIV-negative	HIV-positive	p-Value	Total	HIV-negative	HIV-positive	p-Value
	n = 962	n = 535	n = 427		n = 630	n = 309	n = 321
HPV 6	10 (1.0)	4 (0.8)	6 (1.4)	0.35	1 (0.2)	0 (0.0)	1 (0.3)	1.00
HPV 11	15 (1.6)	6 (1.1)	9 (2.1)	0.29	2 (0.3)	1 (0.3)	1 (0.3)	1.00
HPV 34	1 (0.1)	0 (0.0)	1 (0.2)	0.44	0 (0.0)	0 (0.0)	0 (0.0)	–
HPV 40	4 (0.4)	1 (0.2)	3 (0.7)	0.32	0 (0.0)	0 (0.0)	0 (0.0)	–
HPV 42	3 (0.3)	0 (0.0)	3 (0.7)	0.08	1 (0.2)	0 (0.0)	1 (0.3)	1.00
HPV 43	6 (0.6)	2 (0.4)	4 (0.9)	0.41	2 (0.3)	0 (0.0)	2 (0.6)	0.49
HPV 44	22 (2.3)	4 (0.8)	18 (4.2)	<0.01	7 (1.1)	0 (0.0)	7 (2.2)	0.01
HPV 53	21 (2.2)	10 (1.9)	11 (2.6)	0.50	4 (0.6)	2 (0.6)	2 (0.6)	1.00
HPV 54	17 (1.8)	3 (0.6)	14 (3.3)	<0.01	3 (0.5)	2 (0.6)	1 (0.3)	0.61
HPV 66	28 (2.9)	5 (0.9)	23 (5.4)	<0.01	9 (1.4)	1 (0.3)	8 (2.5)	0.03
HPV 70	16 (1.7)	4 (0.8)	12 (2.8)	0.01	6 (0.9)	1 (0.3)	5 (1.6)	0.21
HPV 74	11 (1.1)	2 (0.4)	9 (2.1)	0.01	1 (0.2)	0 (0.0)	1 (0.3)	1.00
HPV 68/73	16 (1.8)	10 (2.2)	6 (1.4)	0.62	5 (0.8)	5 (1.6)	0 (0.0)	0.02
Unspecified (U)	54 (5.6)	31 (5.8)	23 (5.4)	0.88	11 (1.7)	7 (2.3)	4 (1.3)	0.37